LCG
DMTK

Lisanti Capital Growth’s DermTech, Inc. Common Stock DMTK Stock Holding History

Lisanti Capital Growth’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-136,135
Closed -$5.66M – 172
2021
Q2 		$5.66M Buy
136,135
+21,190
+18% +$870K 0.7% 63
2021
Q1 		$5.84M Buy
+114,945
New +$6.01M 0.75% 61

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Lisanti Capital Growth's DMTK Position: Q3 2021 in Review

Lisanti Capital Growth sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 136,135 shares — an estimated $5.66M sold.

Lisanti Capital Growth first reported a position in DMTK in Q1 2021 and held it in 2 quarters. The position peaked at $5.84M in Q1 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Lisanti Capital Growth reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Lisanti Capital Growth sold 136,135 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $5.66M.
  • Lisanti Capital Growth first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Lisanti Capital Growth's DermTech, Inc. Common Stock position peaked at $5.84M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Lisanti Capital Growth's 13F filing for Q3 2021, filed 3 Nov 2021.